Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2025-12-24 @ 9:09 PM
NCT ID:
NCT00391404
Eligibility Criteria:
Inclusion Criteria:
* Chinese patients who completed treatments for childhood cancers for at least 5 years
* Currently followed up in the Department of Paediatrics of Prince of Wales Hospital
* Younger than 18 years old at the time of diagnosis of underlying cancers
* Evidence of osteoporosis (i.e. BMD T- or Z-score \< -2.5 at lumbar spine)
* Older than 15 years of age at the time of recruitment
Exclusion Criteria:
* Current treatment (i.e. within 6 months) with maintenance systemic or high-dose inhaled corticosteroids
* Subjects who cannot cooperate for BMD measurements
* Pregnant female patients
* Subjects with prior history of allergy to alendronate or in whom alendronate treatment is contraindicated
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
15 Years
Study:
NCT00391404
Study Brief:
Protocol Section:
NCT00391404